IOVANCE BIOTHERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Iovance Biotherapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Iovance Biotherapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 297M shares, a 32.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 297M +72.6M +32.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 280M +55.4M +24.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 256M +68.3M +36.4% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 256M +98M +62.1% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 225M +66.9M +42.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 224M +67.2M +42.8% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 188M +30.8M +19.6% Dec 31, 2022 10-K 2024-02-28
Q3 2022 158M +1.14M +0.73% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 158M +3M +1.94% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 157M +7.85M +5.26% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 157M +9.13M +6.17% Dec 31, 2021 10-K 2023-02-28
Q3 2021 157M +10.1M +6.91% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 155M +8.36M +5.71% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 149M +22.5M +17.7% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 148M +21.5M +17% Dec 31, 2020 10-K 2022-02-24
Q3 2020 147M +20.4M +16.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 146M +22.6M +18.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 127M +3.43M +2.78% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 126M +3M +2.43% Dec 31, 2019 10-K 2021-02-25
Q3 2019 126M +28.8M +29.5% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 124M +31.1M +33.5% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 123M +33.8M +37.7% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 123M +50.3M +68.7% Dec 31, 2018 10-K 2020-02-25
Q3 2018 97.4M +25.5M +35.4% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 92.7M +30.1M +48% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 89.6M +27.3M +43.7% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 73.2M +10.9M +17.5% Dec 31, 2017 10-K 2019-02-28
Q3 2017 72M +10M +16.2% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 62.7M +4.29M +7.35% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 62.4M +13.8M +28.5% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 62.2M +13.7M +28.2% Dec 31, 2016 10-K 2018-03-12
Q3 2016 61.9M +14.1M +29.6% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 58.4M +11.2M +23.9% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 48.5M +3.64M +8.12% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 48.5M +14.8M +43.8% Dec 31, 2015 10-K 2017-03-09
Q3 2015 47.8M +20.2M +73% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 47.1M +19.9M +73.1% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 44.9M +22.8M +103% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 33.8M +13.7M +68.5% Dec 31, 2014 10-K 2016-03-11
Q3 2014 27.6M +12.6M +83.4% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 27.2M +13.9M +104% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 22.1M +21.3M +2598% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 20M +19.2M +2346% Dec 31, 2013 10-K 2015-03-16
Q3 2013 15.1M -63.2M -80.7% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 13.3M -65M -83% Jun 30, 2013 10-Q 2013-10-23
Q1 2013 819K -77.5M -99% Mar 31, 2013 10-Q 2013-10-23
Q4 2012 819K -77.2M -99% Dec 31, 2012 10-K 2014-03-28
Q3 2012 78.3M +4.65M +6.32% Sep 30, 2012 10-Q 2013-01-25
Q2 2012 78.3M +630K +0.81% Jun 30, 2012 10-Q/A 2012-09-10
Q1 2012 78.3M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 78M +4.36M +5.91% Dec 31, 2011 10-K 2013-09-23
Q3 2011 73.6M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 77.7M Jun 30, 2011 10-Q/A 2011-09-01
Q4 2010 73.6M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.